Loading compare…
3 funds hold both · as on May 2026
Comparing mutual fund co-ownership helps identify hidden asset concentration. Our reverse lookup database shows that 3 mutual funds hold active equity positions in both Alembic Pharmaceuticals and Suraksha Diagnostic. The scheme with the highest combined exposure is Aditya Birla Sun Life Pharma & Healthcare Fund (Aditya Birla SL MF), which holds a 1.35% stake in Alembic Pharmaceuticals and a 1.06% stake in Suraksha Diagnostic, amounting to a combined conviction weight of 2.40%.
When multiple mutual funds in your portfolio double-up on the same stock pairs, it limits your diversification benefits. If you also hold either of these companies directly in your demat account, your aggregate exposure is amplified. This co-ownership pattern is standard among index-tracking products but represents active, concentrated strategies in equity schemes.
| Fund | Alembic wt. | Suraksha wt. | Combined |
|---|---|---|---|
| Aditya Birla Sun Life Pharma & Healthcare FundAditya Birla SL MF · Sectoral / Thematic | 1.35% | 1.06% | |
| Kotak Small Cap FundKotak MF · Small Cap | 1.42% | 0.54% | |
| Back to IndexMotilal Oswal MF · Index Fund | 0.30% | 0.04% |
These funds hold both stocks — see how much their entire portfolios overlap.
Check overlap of top funds →“Holds both” = the fund discloses an equity position in each stock in its latest public monthly portfolio (as on May 2026). Weight = the position as a % of that fund's portfolio. ISIN-verified from AMC disclosures. Not investment advice.